CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
Europe - EPA:CLARI - FR0010386334 - Common Stock
4.218 EUR
+0.02 (+0.43%)
Overall CLARI gets a fundamental rating of 3 out of 10. We evaluated CLARI against 28 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CLARI has reported negative net income.
In the past year CLARI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
Each year in the past 5 years CLARI had a positive operating cash flow.
1.2 Ratios
CLARI has a worse Return On Assets (-0.43%) than 75.00% of its industry peers.
Looking at the Return On Equity, with a value of -1.71%, CLARI is doing worse than 71.43% of the companies in the same industry.
CLARI has a Return On Invested Capital of 1.63%. This is in the lower half of the industry: CLARI underperforms 75.00% of its industry peers.
CLARI had an Average Return On Invested Capital over the past 3 years of 1.96%. This is below the industry average of 5.66%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROIC | 1.63% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
CLARI has a Operating Margin (4.80%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CLARI has declined.
With an excellent Gross Margin value of 91.90%, CLARI belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
CLARI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLARI is destroying value.
CLARI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLARI has been increased compared to 5 years ago.
Compared to 1 year ago, CLARI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.63, we must say that CLARI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.63, CLARI is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
CLARI has a debt to FCF ratio of 13.25. This is a negative value and a sign of low solvency as CLARI would need 13.25 years to pay back of all of its debts.
CLARI has a Debt to FCF ratio (13.25) which is comparable to the rest of the industry.
CLARI has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CLARI (1.90) is worse than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.46
WACC3.57%
2.3 Liquidity
CLARI has a Current Ratio of 0.67. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.67, CLARI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
CLARI has a Quick Ratio of 0.67. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLARI (0.65) is worse than 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 |
3. Growth
3.1 Past
CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.49%, which is quite impressive.
CLARI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
CLARI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.89% yearly.
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
3.2 Future
CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.64% yearly.
CLARI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.13% yearly.
EPS Next Y163.95%
EPS Next 2Y86.53%
EPS Next 3Y58.55%
EPS Next 5Y39.64%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.13%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 11.64 indicates a reasonable valuation of CLARI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLARI indicates a somewhat cheap valuation: CLARI is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. CLARI is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.64 |
4.2 Price Multiples
CLARI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLARI is cheaper than 64.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLARI indicates a rather cheap valuation: CLARI is cheaper than 92.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.44 | ||
| EV/EBITDA | 8.56 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLARI's earnings are expected to grow with 58.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.53%
EPS Next 3Y58.55%
5. Dividend
5.1 Amount
CLARI has a Yearly Dividend Yield of 10.64%, which is a nice return.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 2.57. CLARI pays more dividend than 100.00% of the companies in the same industry.
CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-110.43%
EPS Next 2Y86.53%
EPS Next 3Y58.55%
EPA:CLARI (9/18/2025, 7:00:00 PM)
4.218
+0.02 (+0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners42.42%
Inst Owner ChangeN/A
Ins Owners5.64%
Ins Owner ChangeN/A
Market Cap1.50B
Analysts77.14
Price Target4.79 (13.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-110.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.45%
PT rev (3m)58.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)11.76%
EPS NY rev (3m)11.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)-1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.64 | ||
| P/S | 0.28 | ||
| P/FCF | 2.44 | ||
| P/OCF | 1.7 | ||
| P/B | 0.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.56 |
EPS(TTM)-0.17
EYN/A
EPS(NY)0.36
Fwd EY8.59%
FCF(TTM)1.73
FCFY41.07%
OCF(TTM)2.47
OCFY58.66%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROCE | 2.21% | ||
| ROIC | 1.63% | ||
| ROICexc | 1.74% | ||
| ROICexgc | 3.53% | ||
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% | ||
| FCFM | 11.64% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Debt/EBITDA | 6.54 | ||
| Cap/Depr | 33.63% | ||
| Cap/Sales | 4.99% | ||
| Interest Coverage | 0.83 | ||
| Cash Conversion | 84.71% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 | ||
| Altman-Z | 0.63 |
F-Score6
WACC3.57%
ROIC/WACC0.46
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y163.95%
EPS Next 2Y86.53%
EPS Next 3Y58.55%
EPS Next 5Y39.64%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.13%
EBIT growth 1Y-22.25%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year308.46%
EBIT Next 3Y69.88%
EBIT Next 5Y38.42%
FCF growth 1Y267.6%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%